Illumina Prices $1B of Convertible Senior Notes | GenomeWeb

NEW YORK (GenomeWeb) – Illumina today priced its $1 billion convertible senior notes offering, which it expects will bring in net proceeds of approximately $985 million.

The $1 billion in senior notes is above the $900 million that the firm proposed on Wednesday when it initially announced the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.